Skip to main content

Table 4 Risk factors for overall survival according to Cox proportional hazards regression model

From: LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics

Characteristics

Total(N)

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

P value

Hazard ratio (95% CI)

P value

Age

367

    

 <  = 65

163

Reference

   

 > 65

204

1.620 (1.154–2.276)

0.005

1.571 (1.029–2.398)

0.036

Pathologic stage

347

    

Stage I

50

Reference

   

Stage II&Stage III&Stage IV

297

2.247 (1.210–4.175)

0.010

1.004 (0.357–2.826)

0.994

T stage

362

    

T1

18

Reference

   

T2&T3&T4

344

8.829 (1.234–63.151)

0.030

1,533,097.7526 (0.000-Inf)

0.995

N stage

352

    

N0

107

Reference

   

N1&N2&N3

245

1.925 (1.264–2.931)

0.002

2.023 (1.022—4.004)

0.043

M stage

352

    

M0

327

Reference

   

M1

25

2.254 (1.295–3.924)

0.004

1.300 (0.575–2.943)

0.528

Histologic grade

361

    

G1

10

Reference

   

G2&G3

351

1.957 (0.484–7.910)

0.346

  

Primary therapy outcome

313

    

CR

229

Reference

   

PD&SD&PR

84

4.228 (2.905–6.152)

 < 0.001

4.130 (2.624–6.500)

 < 0.001

Helicobacter pylori infection

162

    

No

144

Reference

   

Yes

18

0.650 (0.279–1.513)

0.317

  

Residual tumor

325

    

R0

294

Reference

   

R1&R2

31

3.445 (2.160–5.494)

 < 0.001

1.169 (0.613–2.228)

0.636

ITGB1

370

    

Low

184

Reference

   

High

186

1.404 (1.008–1.956)

0.045

1.103 (0.695–1.751)

0.676

LUM

370

    

Low

185

Reference

   

High

185

1.433 (1.028–1.997)

0.034

1.830 (1.045–3.203)

0.034

COL5A2

370

    

Low

186

Reference

   

High

184

1.496 (1.073–2.084)

0.017

0.974 (0.571–1.662)

0.923

  1. T Tumor, N Node, M Metastasis, PD Progressive disease, SD Stable disease, PR Partial response, CR Complete response